← Open Payments lookup

LILIT YEGIAZARYAN: Open Payments

NPI 1770668345 · GLENDALE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$682 in 22 payments from 8 companies in 2025. Trend: 2023 $168 · 2024 $1,030 · 2025 $682

Food & beverage: $606Education: $76
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.11$362
Lundbeck LLC3$75
E.R. Squibb & Sons, L.L.C.2$62
Takeda Pharmaceuticals U.S.A., Inc.2$53
Janssen Pharmaceuticals, Inc1$45
Alkermes, Inc.1$34
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$33
Otsuka America Pharmaceutical, Inc.1$17

Products named: UZEDY, AUSTEDO XR, COBENFY, ABILIFY ASIMTUFII, TRINTELLIX, SPRAVATO, REXULTI, VIVITROL.

Industry payments across CA — which companies pay providers there.